ContractTrial Agreement Institution Agreement • November 23rd, 2017
Contract Type FiledNovember 23rd, 2017CLINICAL TRIAL AGREEMENTInstitution Agreement Institution: Krajska zdravotni, a. s. Institution Address: Socialní pece 3316/12a, 401 13 Usti nad Labem, Czech Republic CRO Name: Medpace Clinical Research, LLC CRO Address: 5375 Medpace Way, Cincinnati, Ohio 45227, USA Study Drug: Lesinurad 200 mgProtocol Number and Title: A Phase 4, Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Evaluate the Safety and Efficacy of Lesinurad 200 mg in Combination With a Xanthine Oxidase Inhibitor (XOI), Compared With an XOI Alone, in Subjects With Gout and Estimated Creatinine Clearance 30 to<60 mL/min Who Have Not Achieved Target Serum Uric Acid Levels on an XOI Alone Date: 25-September-2017 THIS CLINICAL TRIAL AGREEMENT(together with its Schedules, the "Agreement") is made and entered into as of the date specified above by and between Ironwood Pharmaceuticals, Inc., a Delaware corporation with a principal business address at 301 Binney Street, Cambridge, Massachusetts 02142 ("Sponso